Inventor
LEENAERTS JOSEPH ELISABETH
BE22 patents
⚠️ This page may combine multiple inventors who share the name “LEENAERTS JOSEPH ELISABETH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
20 patentsUS6197772B1Mar 6, 2001
1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives
JANSSEN PHARMACEUTICA NV44 citations95
US7148214B1Dec 12, 2006
Antihistaminic spiro compounds
JANSSEN PHARMACEUTICA NV21 citations92
US6521621B1Feb 18, 2003
1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
JANSSEN PHARMACEUTICA NV32 citations92
US6218381B1Apr 17, 2001
Fused imidazole derivatives as multidrug resistance modulators
JANSSEN PHARMACEUTICA NV6 citations73
US6110939AAug 29, 2000
(Benzimidazolyl- and imidazopyridinyl) containing 1-(1,2-disubstituted piperidinyl) derivatives
JANSSEN PHARMACEUTICA NV15 citations73
US6251894B1Jun 26, 2001
1-(1,2-disubstituted piperidinyl)-4 (fused imidazole)-piperidine derivatives
JANSSEN PHARMACEUTICA NV11 citations72
US7410970B2Aug 12, 2008
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
JANSSEN PHARMACEUTICA NV8 citations71
US7087595B2Aug 8, 2006
Antihistaminic spiro compounds
JANSSEN PHARMACEUTICA NV3 citations62
US5674866AOct 7, 1997
Antiallergic imidazoazepines
JANSSEN PHARMACEUTICA NV2 citations62
US7435736B2Oct 14, 2008
Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
JANSSEN PHARMACEUTICA NV4 citations60
US12006302B2Jun 11, 2024
Tau PET imaging ligands
JANSSEN PHARMACEUTICA NV0 citations56
US11168068B2Nov 9, 2021
Tau PET imaging ligands
JANSSEN PHARMACEUTICA NV0 citations56
US6476018B1Nov 5, 2002
Fused imidazole derivatives as multidrug resistance modulators
JANSSEN PHARMACEUTICA NV0 citations51
US7795261B2Sep 14, 2010
Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
JANSSEN PHARMACEUTICA NV1 citations48
US7732437B2Jun 8, 2010
Use of anti-histaminics for acute reduction of elevated intracranial pressure
JANSSEN PHARMACEUTICA NV2 citations46
US7476662B2Jan 13, 2009
Substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
JANSSEN PHARMACEUTICA NV2 citations46
US7572786B2Aug 11, 2009
Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
JANSSEN PHARMACEUTICA NV0 citations39
US7514424B2Apr 7, 2009
Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
JANSSEN PHARMACEUTICA NV0 citations39
US7282508B2Oct 16, 2007
Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
JANSSEN PHARMACEUTICA NV0 citations39
US7390822B2Jun 24, 2008
Substituted 4-phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage
JANSSEN PHARMACEUTICA NV0 citations33